PremiumCompany AnnouncementsAstraZeneca Expands Real‑World Evidence for Acalabrutinib in CLL1d agoAZN
PremiumCompany AnnouncementsAstraZeneca’s Danicopan Korea Study: Real-World Data That Could Shape AZN’s Rare Disease Edge1d agoAZN
PremiumCompany AnnouncementsShell Advances Capital Return Drive with Further Multivenue Share Buy-Back2d ago